Trial Profile
A Phase 2, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and the Safety of Trafermin in Patients With Marginal Periodontitis in Japan
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2024
Price :
$35
*
At a glance
- Drugs Trafermin (Primary)
- Indications Periodontitis
- Focus Therapeutic Use
- Sponsors Kaken Pharmaceutical
- 17 Jun 2014 New trial record
- 04 Feb 2008
- 19 Sep 2006